Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
New agreement applies to the polymers of the Medical Care series portfolio
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
